RHUMBLINE ADVISERS

Position in TAK — Takeda Pharmaceutical Co Ltd

CIK 1115418 BOSTON, MA

Position in TAK

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$1,946,458

-$306,703 QoQ

Shares Held

121,426

-0.2% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#74

of 376 holders

Holding Since

Sep 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $455,921,156 across 48 Drug Manufacturers - Specialty & Generic names. TAK ranks #23 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	1,437,213	$103,278,126
2	UTHR	UNITED THERAPEUTICS Corp	120,078	$65,061,862
3	NBIX	Neurocrine Biosciences Inc	312,832	$52,724,705
4	VTRS	Viatris Inc	2,872,464	$45,614,728
5	ELAN	Elanco Animal Health Inc	1,264,159	$31,110,952
6	HIMS	Hims & Hers Health, Inc.	633,778	$21,973,083
7	LNTH	Lantheus Holdings, Inc.	197,060	$21,861,836
8	ALKS	Alkermes plc.	387,999	$20,331,147

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,946,458	121,426	-0.2%	Shares	Sole	2026-08-12
2026-03-31	$2,253,161	121,661	+3.4%	Shares	Sole	2026-05-12
2025-12-31	$1,833,945	117,636	+95.5%	Shares	Sole	2026-02-13
2025-09-30	$881,035	60,180	-11.4%	Shares	Sole	2025-11-06
2025-06-30	$1,049,734	67,900	-3.9%	Shares	Sole	2025-08-12
2025-03-31	$1,050,297	70,632	-5.2%	Shares	Sole	2025-05-29
2024-12-31	$986,869	74,537	+0.3%	Shares	Sole	2025-05-29
2024-09-30	$1,057,242	74,349	0.0%	Shares	Sole	2024-11-12
2024-06-30	$962,076	74,349	+9.3%	Shares	Sole	2024-08-01
2024-03-31	$945,158	68,046	+18.1%	Shares	Sole	2024-05-09
2023-12-31	$822,323	57,626	-0.5%	Shares	Sole	2024-02-08
2023-09-30	$895,573	57,891	+1.0%	Shares	Sole	2023-11-09
2023-06-30	$900,434	57,316	+281.2%	Shares	Sole	2023-08-08
2020-12-31	$273,655	15,036	+33.5%	Shares	Sole	2021-02-10
2020-09-30	$200,985	11,266	—	Shares	Sole	2020-11-12
No filing history on record for this holder in this stock.